CD68 and neoplasm: We have aimed to study the five-year disease-specific survival (DSS) of newly diagnosed OPSCC patients dependent on the activation level of TILs measured by level of CD3 and Foxp3-positive TILs, as well as the level of tumor-associated macrophages (TAM) measured by CD68-positive cells.